Overview

Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis

Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if corticosteroid injection modifies the natural course of de Quervain tendinopathy compared to a toradol injection.
Phase:
Phase 4
Details
Lead Sponsor:
OrthoCarolina Research Institute, Inc.
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Epinephrine
Epinephryl borate
Ketorolac
Ketorolac Tromethamine
Lidocaine
Racepinephrine